Results

1–10 of 18 results for John T. Thompson

Expert Panel: Faricimab and Aflibercept 8 mg in AMD
John T. Thompson, MD
Andrew A. Moshfeghi, MD, MBA, FASRS
Manjot K Gill, MD, FASRS
Christina Y Weng, MD, MBA, FASRS
Ferhina S Ali, MD, MPH
Ian Pearce, MB ChB BSc FRCOPHTH
Annual Meeting Talks
2024
Expert Panel: Macular Holes
Zofia Anna Nawrocka (vel Michalewska), MD, PhD
Rajeev H. Muni, MD, MSC, FRCS(C), FASRS
Russel H. Dinh, MD
SHILPI H NARNAWARE, ICO ( Retina) , FAICO ( Vitreo-Retina)
John T. Thompson, MD
Annual Meeting Talks
2024
Macular Hole Surgery Results With Long-Acting Gas Tamponade and Internal Limiting Membrane Removal
John T. Thompson, MD
Annual Meeting Talks
2022
The Conundrum of Intravitreal Injections and Use of -25 Modifier for Same-Day Office Visits
John T. Thompson, MD
Annual Meeting Talks
2021
Physician Quality Outcome Measures Don’t Reliably Measure Quality for Individual Ophthalmologists
John T. Thompson, MD
Annual Meeting Talks
2020
Differences in Intravitreal Silicone Oil Following Multiple Bevacizumab, Ranibizumab, and Aflibercept Injections
John T. Thompson, MD
Updates from the Field
2019
Retina PractiCare 2.0 - Benchmarking Your Practice Health
John T. Thompson, MD
Annual Meeting Talks
2019
Differences in Intravitreal Silicone Oil Following Multiple Bevacizumab, Ranibizumab, and Aflibercept Injections
John T. Thompson, MD
Annual Meeting Talks
2019
Retina PractiCare: Coding Benchmarks for Retina Specialists
John T. Thompson, MD
Annual Meeting Talks
2016
Relativity, Time, and the Devaluation of Retinal Procedures During the Past Decade
John T. Thompson, MD
Updates from the Field
2018